Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FLT-PET Activity Change After Allogeneic Umbilical Cord Blood in Cerebral Palsy
NCT01486732Phase 2Withdrawn
- Sponsor
- Cambridge Health Alliance
- Start
- Mar 2013
- Primary completion
- Apr 2014
- Modality
- Hematopoietic Stem Cells
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in cerebral palsy (CP) comparing Umbilical Cord Blood with Placebo (2 arms). Primary endpoint: Comparison of FLT-PET Activity Change at 2 weeks. Planned start Mar 2013; status: withdrawn.
02
Drugs
umbilical cord blood
03
Conditions
cerebral palsy (CP)
Beyond the preview
Go deeper on NCT01486732.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01486732.